Closed Loop Medicine is a Tech Bio company developing prescription combination drugs + software products, to bring forward the promise of precision medicine.
We're thrilled to announce that our study, describing the breakthrough results of the PERSONAL-CovidPB clinical trial, has been published in @JAHA_AHA.
Read the full press release to learn how we're using these data: https://t.co/iH6OQWFkAZ
We have been selected to join #NVIDIAinception, an accelerator program led by world-leading AI Computing company, @nvidia, designed to nurture startups and early-stage companies revolutionizing industries with technological advancements. Read more: https://t.co/ILXgWKyAF2
.@AmDiabetesAssn returns for its 84th Annual Scientific Session on June 21st! #ADA2024
Arrange a meeting with @hakim_yadi to discuss how we are facilitating personalized disease management to improve the effectiveness of medicines, such as GLP-1s: https://t.co/YXlcsi0fwY
In this interview with @EBRmagazine our CEO @hakim_yadi shared his insights on the global impact of mismanaged #hypertension, current healthcare limitations, and how novel technology applications and personalized dosing can revolutionize treatment, p.39-41 https://t.co/oN2OcTSzu6
In this @INVIVOnow podcast, our CEO @Hakim_Yadi discussed how Closed Loop Medicine’s approach in pairing software as a medical device with advanced analytics and drugs can enhance personalized care across multiple therapeutic areas. Listen here: https://t.co/DuMXu9Qp2o
Today we welcome Paul Johnson to the Board as a Non-Executive Director. With extensive experience in digital #healthcare and e-commerce, Paul joins to support the commercialization strategy for our integrated #precision care solutions: https://t.co/AqAgDQFR5D
Tomorrow is #WorldHypertensionDay. Together with Pharmanovia, we are excited to announce the first patient recruitment and of a study investigating personalized dose management of an anti-hypertensive in improving blood pressure control.
COR2024SM00107
Date Prepared: May 2024
The #PrixGalien UK Forum returns on May 30, celebrating excellence in medical research. Attending as a panelist is our CEO, @Hakim_Yadi for the session titled, “Introducing new technologies: optimising pathways to improve population health.” https://t.co/HHi9dnWkTb
In case you missed it, our CEO @Hakim_Yadi sat with @BioCentury to discuss how applying real-time PK/PD monitoring to personalize the dosing of #GLP1s can improve patient outcomes.
Read the full article at BioCentury: https://t.co/1yf0cB2MHd
#Obesity#PrecisionCare#TechBio
Curious about how #translationalscience can bridge the gap between basic research and clinical applications? Join our CEO @hakim_yadi at @lifearc1’s Translational Science Summit for an insightful day of exploration and discovery.
For more info visit: https://t.co/Krjzy0uxKV
Watch this video abstract outlining our clinical trial findings in @JAHA_AHA, which validate the use of our proprietary technology for the identification of a personalized dose regimen for the management of #hypertension: https://t.co/jBAKA6nETy
Few weeks left until #BioTrinity 2024, @OBN_UK’s premier event! Hear from CEO @Hakim_Yadi on April 24 at the Platforms For Drug Discovery & Development Spotlight. Discover how Closed Loop Medicine delivers #precisioncare: https://t.co/AGPOFPz6PJ
Have you listened to @BioCentury’s This Week podcast, where @jeff_cranmer and @StephenPHansen discuss our precision care approach for enhancing the tolerance and efficacy of obesity treatments without limiting market size.
Listen to the episode here: https://t.co/WvM4DqFz0H
🆕@closed_loop_med and Teva UK forge strategic partnership to revolutionize Personalized Medicines https://t.co/a3x4nxr3O6. 👏Kudos to Hakim Yadi OBE, CEO & Co-Founder, who delivered an insightful plenary keynote at #FH23 on personalized medicine. https://t.co/crYdo3qclC
We’re excited to announce a strategic partnership with @Teva_UK, a collaboration aimed at advancing the development of personalized medicines. Read the full press release here: https://t.co/CAWP0pi16I
#PrecisionCare#DigitalHealth#TechBio#ChronicDisease
“What we’re saying is there’s an opportunity to use real-time, real-world PK/PD to personalize dosing of products like GLP-1s.” - @hakim_yadi, @Closed_Loop_Med
Discover strategies for precision medicine in tackling obesity without market size limits: https://t.co/hMAthxFOqI
Today is #InternationalWomensDay. #WomensHealth has been neglected in clinical trials limiting treatment success. Personalized dose optimization can help ensure optimal outcomes for each individual. Learn more about our mission to deliver #precisioncare: https://t.co/FZqPurVU7y